Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 24 studies | 38% ± 20% | |
regulatory T cell | 22 studies | 33% ± 11% | |
microglial cell | 11 studies | 45% ± 13% | |
dendritic cell | 9 studies | 39% ± 13% | |
adipocyte | 8 studies | 44% ± 11% | |
fibroblast | 8 studies | 25% ± 9% | |
macrophage | 8 studies | 33% ± 11% | |
glutamatergic neuron | 7 studies | 40% ± 20% | |
GABAergic neuron | 7 studies | 45% ± 22% | |
interneuron | 6 studies | 45% ± 18% | |
cardiac muscle cell | 6 studies | 57% ± 24% | |
plasmacytoid dendritic cell | 6 studies | 20% ± 4% | |
neuron | 5 studies | 35% ± 24% | |
pericyte | 5 studies | 26% ± 6% | |
kidney loop of Henle epithelial cell | 5 studies | 39% ± 21% | |
T follicular helper cell | 5 studies | 26% ± 9% | |
type II pneumocyte | 5 studies | 30% ± 7% | |
myeloid cell | 4 studies | 21% ± 6% | |
endothelial cell of lymphatic vessel | 4 studies | 25% ± 3% | |
astrocyte | 4 studies | 28% ± 17% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 3% | |
ionocyte | 3 studies | 37% ± 5% | |
CD4-positive, alpha-beta T cell | 3 studies | 19% ± 3% | |
GABAergic interneuron | 3 studies | 26% ± 8% | |
epithelial cell | 3 studies | 20% ± 3% | |
basal cell | 3 studies | 19% ± 2% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 30% ± 8% | |
renal alpha-intercalated cell | 3 studies | 55% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 4635.40 | 459 / 459 | 99% | 22.54 | 1102 / 1118 |
kidney | 100% | 4449.55 | 89 / 89 | 98% | 27.84 | 879 / 901 |
esophagus | 98% | 2219.02 | 1422 / 1445 | 99% | 22.53 | 181 / 183 |
prostate | 97% | 3398.83 | 238 / 245 | 100% | 39.62 | 500 / 502 |
adrenal gland | 100% | 20761.69 | 258 / 258 | 96% | 23.51 | 221 / 230 |
pancreas | 99% | 1905.29 | 325 / 328 | 96% | 13.76 | 171 / 178 |
thymus | 100% | 6596.88 | 653 / 653 | 94% | 16.49 | 567 / 605 |
lung | 98% | 2584.61 | 567 / 578 | 95% | 13.88 | 1096 / 1155 |
skin | 100% | 4540.33 | 1808 / 1809 | 93% | 37.35 | 439 / 472 |
brain | 94% | 1578.19 | 2485 / 2642 | 97% | 11.60 | 686 / 705 |
stomach | 94% | 2444.36 | 339 / 359 | 95% | 23.36 | 272 / 286 |
uterus | 100% | 2573.64 | 170 / 170 | 87% | 12.82 | 401 / 459 |
bladder | 95% | 1791.76 | 20 / 21 | 91% | 14.64 | 458 / 504 |
intestine | 85% | 1949.07 | 820 / 966 | 97% | 24.23 | 512 / 527 |
ovary | 100% | 9360.51 | 180 / 180 | 60% | 4.72 | 260 / 430 |
liver | 88% | 1168.97 | 199 / 226 | 65% | 7.63 | 265 / 406 |
adipose | 100% | 4050.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 12749.33 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4610.42 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 5482.01 | 837 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 28.24 | 75 / 80 |
tonsil | 0% | 0 | 0 / 0 | 87% | 14.55 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 26.31 | 25 / 29 |
blood vessel | 82% | 1280.64 | 1094 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 30% | 897.39 | 280 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0031339 | Biological process | negative regulation of vesicle fusion |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0005829 | Cellular component | cytosol |
GO_0031982 | Cellular component | vesicle |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | TBC1D4 |
Protein name | TBC1 domain family member 4 TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160) |
Synonyms | KIAA0603 AS160 |
Description | FUNCTION: May act as a GTPase-activating protein for RAB2A, RAB8A, RAB10 and RAB14. Isoform 2 promotes insulin-induced glucose transporter SLC2A4/GLUT4 translocation at the plasma membrane, thus increasing glucose uptake. . |
Accessions | ENST00000413735.1 ENST00000431480.6 [O60343-3] ENST00000377625.6 [O60343-2] Q5JU47 O60343 ENST00000377636.8 [O60343-1] A0A3B3IRT3 ENST00000648194.1 |